Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
IGC Pharma, Inc. (IGC) had Debt to Capital Ratio of 0.02 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.26M |
|
$-1.83M |
|
$0.15M |
|
$0.10M |
|
$2.13M |
|
$-1.88M |
|
$0.05M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.88M |
|
$-1.72M |
|
77.63M |
|
77.63M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$3.05M |
|
$3.35M |
|
$6.03M |
|
$9.08M |
|
$2.66M |
|
$0.13M |
|
$0.16M |
|
$2.82M |
|
$6.26M |
|
$4.39M |
|
$6.26M |
|
78.20M |
|
| Cash Flow Statement Financials | |
$-4.07M |
|
$-0.30M |
|
$3.65M |
|
$1.20M |
|
$0.47M |
|
$-0.73M |
|
$1.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.02 |
0.02 |
|
40.47% |
|
-730.74% |
|
-730.74% |
|
-- |
|
-711.67% |
|
-711.67% |
|
$-4.14M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.11 |
|
5.24 |
|
17.16 |
|
-29.22% |
|
-41.66% |
|
-20.15% |
|
-28.61% |
|
$0.08 |
|
$-0.05 |
|
$-0.05 |
|